Improving clinical trials for Parkinson’s
Rallying to the Challenge 2024: recorded to watch again
Rallying to the Challenge is a meeting designed for and by people with Parkinson’s, advocates and care partners to explore how the Parkinson’s community can impact and accelerate research.
Parkinson’s and dementia: improving cognitive measures to enable better treatments
Recently, several international Parkinson’s and Dementia with Lewy Bodies (DLB) advocacy organizations, including Cure Parkinson’s, held a roundtable to discuss the development of better tools for measuring cognitive changes…
Accelerating Parkinson’s drug development: The International Linked Clinical Trials initiative
In 2012, Cure Parkinson’s joined forces with Van Andel Institute (VAI) to hold the first international Linked Clinical Trials (iLCT) meeting in Grand Rapids, Michigan. The Committee has since…
Moving towards a new staging system for Parkinson’s
Cure Parkinson’s has been a part of a group of Parkinson’s scientists, charity organizations, and patient advocates from around the world to help develop a new biological staging framework…
Exploring Perspectives on Trial Design for Parkinson’s: An Update on the Delphi Study
Recently, Cure Parkinson’s was pleased to see the results of one of our funded studies published in the Journal of Parkinson’s Disease.
The new Multi-arm Multi-stage MAMS trial model for Parkinson’s
One of the most frustrating aspects of the way we currently conduct clinical trials is the long delays between studies. Multi-Arm, Multi-Stage (or MAMS) clinical trials may represent a…
Our 2023 research impact report
Our recent research impact report determines and highlights the impact our research funding has had on the Parkinson’s research field.
Research Update Meeting Spring 2023 – recorded to watch again
Our popular and much-awaited research update meeting brought together two leading clinicians to report on their individual area of expertise for Parkinson’s. It’s available to watch again!
The 2022 International Linked Clinical Trials meeting
Cure Parkinson’s annually coordinates the International Linked Clinical Trials (iLCT) meeting to rank and prioritise therapies that may have the potential to modify the course of Parkinson’s progression.
The 2022 Parkinson’s drug development pipeline report
The 2022 annual report, outlining the current development pipeline of new drug-based treatments for Parkinson’s, has been published.
Parkinson’s Clinical Study Group
Cure Parkinson’s is funding Professor Oliver Bandmann at the University of Sheffield to establish a nationwide infrastructure for a study group focused specifically on conducting clinical trials for Parkinson’s….
Improving Parkinson’s Trials: A Delphi Study
Under the visionary leadership of Dr Camille Carroll at the University of Plymouth, Cure Parkinson’s has been supporting an exploratory study at the University of Plymouth to understand the…
Multi-Arm Multi-Stage – a new approach to clinical trials
One of the most frustrating aspects of clinical trials is the long delays between studies. Dr Camille Carroll is leading a group of researchers exploring the use of multi-arm…
Multi-Arm Multi-Stage trials for Parkinson’s
At present, most clinical trials for Parkinson’s involve a single therapy, being tested against a ‘placebo’ or control treatment for a fixed period of time. At the end of…